Medical Policies
Medical policies are documents that define the plan coverage for technologies, procedures and treatments. The statements of medical necessity in the policies, about whether a technology, procedure, treatment, supply, equipment, drug or other service improves the health outcome of the population for which said technology or treatment was designed are based on scientific evidence, clinical studies and professional opinions from our providers and recognized medical organizations.
Each document displayed on this website is provided for informational purposes only and is not an authorization, explanation of benefits, or contract. Receiving benefits is subject to satisfaction of all terms and conditions of coverage. Medical technology is constantly changing, and we reserve the right to periodically review and update our policies.
Medical Policies table
| ID | Title | Review | Description | Access |
|---|---|---|---|---|
| 03.001.009 | Digital Health Therapies For Substance Abuse | Aug 2024 | The world health organization defines substance use disorder as “the harmful or hazardous use of... | View |
| 03.001.010 | Digital Health Therapies For Attention Deficit/Hyperactivity Disorder | Aug 2026 | Digital health technologies is a broad term that includes categories such as mobile health, health... | View |
| 03.003.001 | Therapeutic Radiopharmaceuticals for Prostate Cancer | Nov 2025 | ... | View |
| 04.001.001 | Evaluación fetal anteparto | Jun 2022 | In humans as well as in animals, the fetal heart rate pattern, activity level, and degree of fetal muscle... | View |
| 04.001.003 | Home Uterine Activity Monitoring | May 2019 | The home uterine activity monitor (huam) is a device that can be worn by pregnant women and is intended to... | View |
| 04.001.007 | Occlusion Of Uterine Arteries Using Transcatheter Embolization | Sep 2020 | ... | View |
| 04.001.009 | Laparoscopic And Percutaneous Techniques For The Myolysis Of Uterine Fibroids | Mar 2026 | Various minimally invasive treatments for uterine fibroids have been proposed as alternatives to surgery.... | View |
| 04.001.010 | Oclusión histeroscópica de los tubos de falopio como método contraceptivo | May 2016 | ... | View |
| 04.001.011 | Ovarian And Internal Iliac Vein Endovascular Occlusion As A Treatment Of Pelvic Congestion Syndrome | Sep 2026 | Pelvic congestion syndrome is characterized by chronic pelvic pain that is often aggravated by standing;... | View |
| 04.001.012 | Progesterone Therapy As A Technique To Reduce Preterm Delivery In High-Risk Pregnancies | Oct 2024 | Preterm birth is the leading cause of neonatal morbidity and mortality, and effective primary preventive... | View |
| 04.001.013 | Ablación del Endometrio | Aug 2017 | ... | View |
| 04.001.019 | Robotic Surgery In Gynecology | Oct 2023 | In the decade of the ‘80s, the idea of having a military ambulance in the battlefield; equipped with a... | View |
| 04.001.020 | Obstetric Ultrasonography | Sep 2024 | Obstetric ultrasonography is an ultrasound examination with an instrument in real time, using transabdominal... | View |
| 04.001.024 | Services For Intra-Uterine Device Management | Nov 2022 | The intrauterine device (iud) is the most commonly used method of long-acting reversible contraception... | View |
| 04.002.002 | Cirugía fetal para malformaciones congénitas diagnosticadas en periodo perinatal | Dec 2022 | Fetal surgery is used for specific congenital abnormalities associated with a poor postnatal prognosis.... | View |
| 04.002.004 | GENDER AFFIRMING SURGERY | Aug 2026 | This policy addresses gender affirming surgery (also known as sex affirmation surgery, gender or sex... | View |
| 04.002.005 | Reproductive Techniques | Sep 2026 | A variety of techniques are available to establish a viable pregnancy for couples who have been diagnosed... | View |
| 05.001.004 | Botulinum Toxin | Nov 2025 | Botulinum is a family of toxins produced by the anaerobic organism clostridia botulinum. multiple... | View |
| 05.001.005 | Human Growth Hormone | Nov 2025 | Recombinant human growth hormone (gh) is approved by the u.s. food and drug administration (fda) for various... | View |
| 05.001.006 | Recombinant And Autologous Platelet-Derived Growth Factors For Wound Healing And Other Non‒Orthopedic Conditions | Feb 2026 | The use of blood-derived growth factors, including recombinant platelet-derived growth factors (pdgfs) and... | View |
